Changeflow GovPing Courts & Legal Kaneka Corporation v. Designs For Health, Inc.,...
Priority review Enforcement Added Final

Kaneka Corporation v. Designs For Health, Inc., et al.

Favicon for www.ded.uscourts.gov D. Delaware Opinions
Filed April 7th, 2026
Detected April 8th, 2026
Email

Summary

The United States District Court for the District of Delaware issued a ruling in Case 21-209 filed by Kaneka Corporation against Designs For Health, Inc. and related parties. Judge William C. Bryson presided over the matter with an opinion issued on April 7, 2026. The case involves a patent or intellectual property dispute between the parties.

What changed

The District Court for the District of Delaware issued a judgment in Kaneka Corporation v. Designs For Health, Inc., et al., Case 21-209. The opinion, authored by Judge William C. Bryson, addresses a dispute between Kaneka Corporation and Designs For Health, likely concerning patent infringement or intellectual property claims related to dietary supplements or nutritional products.

Affected parties—including dietary supplement manufacturers, pharmaceutical companies, and businesses in the health product industry—should monitor this opinion for precedential value on patent validity, infringement standards, or claim construction issues. The ruling may establish standards applicable to similar intellectual property disputes in the nutraceutical and supplement sectors.

What to do next

  1. Review the court opinion to assess litigation exposure
  2. Evaluate patent portfolio for potential infringement vulnerabilities
  3. Consult intellectual property counsel regarding any enforcement implications

Source document (simplified)

You are here

  • Home # Kaneka Corporation v. Designs For Health, Inc., et al.

Case: 21-209 Judge: Judge William C. Bryson Date: 04/07/2026

21-209.pdf

Get daily alerts for D. Delaware Opinions

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
D. Delaware
Filed
April 7th, 2026
Instrument
Enforcement
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
Case No. 21-209 (D. Del. Apr. 7, 2026)
Docket
21-209

Who this affects

Applies to
Drug manufacturers Manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent litigation IP infringement claims Product manufacturing disputes
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when D. Delaware Opinions publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.